Author

Lukas Theissen

Institutions: BG University Hospital Bergmannsheil Bochum, Ruhr University Bochum

Observed institutions: Düsseldorf University Hospital, BG University Hospital Bergmannsheil Bochum, Heinrich Heine University Düsseldorf, Ruhr University Bochum

OpenAlex ID: A5092508937

Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis

2023 · Christopher Nelke, Christina B. Schroeter, et al. · Acta Neuropathologica · 32

Current Biomarker Strategies in Autoimmune Neuromuscular Diseases

2023 · Menekse Oeztuerk, Antonia Henes, et al. · Cells · 18

Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering

2024 · Christopher Nelke, Christina B. Schroeter, et al. · EBioMedicine · 14

Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis

2024 · Christina B. Schroeter, Christopher Nelke, et al. · Acta Neuropathologica · 12

Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice

2024 · Lukas Theissen, Christina B. Schroeter, et al. · Cells · 9

K2P2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathies

2023 · Christopher Nelke, Thomas Müntefering, et al. · Journal of Autoimmunity · 5

4.31eP A simplified murine model of experimental autoimmune myasthenia gravis (EAMG)

2026 · Lukas Theissen, Christopher Nelke, et al. · Neuromuscular Disorders

Age and Treatment Efficacy in Myasthenia Gravis: A Systematic Review, Meta‐Analysis, and Meta‐Regression

2026 · Christopher Nelke, Marion Skrobol, et al. · European Journal of Neurology

Recombinant acetylcholine receptor immunization induces a robust model of experimental autoimmune myasthenia gravis in mice

2023 · Christopher Nelke, Lukas Theissen, et al. · Research Square

Works count: 9

Citation count: 90

H-index: 5

I10-index: 4